Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | 17-AAG | 1 | uM | 10 | 156.25 | 46.73 | 61.00 | 94.75 | 0.6438 | 0.2987 |
| MCF7 | Linsitinib | 10 | uM | 10 | 156.25 | 46.73 | 67.00 | 94.75 | 0.7071 | 0.4238 |
| MCF7 | 17-AAG | 0.1 | uM | 10 | 156.25 | 46.73 | 50.00 | 94.75 | 0.5277 | 0.0686 |
| MCF7 | Lapatinib | 0.01 | uM | 10 | 156.25 | 46.73 | 167.00 | 94.75 | 1.7625 | 2.4864 |
| MCF7 | 17-AAG | 0.031623 | uM | 10 | 156.25 | 46.73 | 87.00 | 94.75 | 0.9182 | 0.8395 |
| MCF7 | Lapatinib | 0.1 | uM | 10 | 156.25 | 46.73 | 224.00 | 94.75 | 2.3641 | 3.6497 |
| MCF7 | Lapatinib | 0.031623 | uM | 10 | 156.25 | 46.73 | 147.00 | 94.75 | 1.5515 | 2.0765 |
| MCF7 | Linsitinib | 3.1623 | uM | 10 | 156.25 | 46.73 | 80.00 | 94.75 | 0.8443 | 0.6942 |
| MCF7 | 0 | uM | 10 | 156.25 | 46.73 | 126.00 | 94.75 | 1.3298 | 1.6449 | |
| MCF7 | Erlotinib | 0.1 | uM | 10 | 156.25 | 46.73 | 169.00 | 94.75 | 1.7836 | 2.5273 |
| MCF7 | Linsitinib | 0.31623 | uM | 10 | 156.25 | 46.73 | 129.00 | 94.75 | 1.3615 | 1.7066 |
| MCF7 | Linsitinib | 0.1 | uM | 10 | 156.25 | 46.73 | 74.00 | 94.75 | 0.7810 | 0.5695 |
| MCF7 | Erlotinib | 1 | uM | 10 | 156.25 | 46.73 | 105.00 | 94.75 | 1.1082 | 1.2119 |
| MCF7 | Linsitinib | 19.9526 | uM | 10 | 156.25 | 46.73 | 67.00 | 94.75 | 0.7071 | 0.4238 |
| MCF7 | Erlotinib | 0.031623 | uM | 10 | 156.25 | 46.73 | 152.00 | 94.75 | 1.6042 | 2.1790 |
| MCF7 | 0 | uM | 10 | 156.25 | 46.73 | 73.00 | 94.75 | 0.7705 | 0.5487 | |
| MCF7 | 17-AAG | 3.1623 | uM | 10 | 156.25 | 46.73 | 26.00 | 94.75 | 0.2744 | -0.4372 |
| MCF7 | 0 | uM | 10 | 156.25 | 46.73 | 52.00 | 94.75 | 0.5488 | 0.1105 | |
| MCF7 | 0 | uM | 10 | 156.25 | 46.73 | 100.00 | 94.75 | 1.0554 | 1.1086 | |
| MCF7 | 17-AAG | 10 | uM | 10 | 156.25 | 46.73 | 26.00 | 94.75 | 0.2744 | -0.4372 |
| MCF7 | 17-AAG | 0.0016596 | uM | 10 | 156.25 | 46.73 | 152.00 | 94.75 | 1.6042 | 2.1790 |
| MCF7 | Lapatinib | 0.0033113 | uM | 10 | 156.25 | 46.73 | 201.00 | 94.75 | 2.1214 | 3.1811 |
| MCF7 | Erlotinib | 0.01 | uM | 10 | 156.25 | 46.73 | 140.00 | 94.75 | 1.4776 | 1.9328 |
| MCF7 | 0 | uM | 10 | 156.25 | 46.73 | 204.00 | 94.75 | 2.1530 | 3.2422 | |
| MCF7 | Erlotinib | 3.1623 | uM | 10 | 156.25 | 46.73 | 189.00 | 94.75 | 1.9947 | 2.9362 |